Hashemi SMS - Search Results

1

Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC.

Jebbink M, de Langen AJ, Monkhorst K, Boelens MC, van den Broek D, van der Noort V, de Gooijer CJ, Mahn M, van der Wekken AJ, Hendriks L, Hashemi SMS, Paats MS, Dingemans AC, Smit EF. Jebbink M, et al. Among authors: hashemi sms. JTO Clin Res Rep. 2023 Feb 24;4(4):100481. doi: 10.1016/j.jtocrr.2023.100481. eCollection 2023 Apr. JTO Clin Res Rep. 2023. PMID: 37035409 Free PMC article.

2

Complications of endoscopic ultrasound-guided needle aspiration.

Hashemi SM, Dahele M, Daniels JM, Smit EF. Hashemi SM, et al. Acta Oncol. 2014 Sep;53(9):1265-8. doi: 10.3109/0284186X.2014.887855. Epub 2014 Mar 25. Acta Oncol. 2014. PMID: 24666266 Review. No abstract available.

3

Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung Cancer.

Tekatli H, Haasbeek N, Dahele M, De Haan P, Verbakel W, Bongers E, Hashemi S, Nossent E, Spoelstra F, de Langen AJ, Slotman B, Senan S. Tekatli H, et al. J Thorac Oncol. 2016 Jul;11(7):1081-9. doi: 10.1016/j.jtho.2016.03.008. Epub 2016 Mar 21. J Thorac Oncol. 2016. PMID: 27013408 Free article.

4

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.

Kuiper JL, Hashemi SM, Thunnissen E, Snijders PJ, Grünberg K, Bloemena E, Sie D, Postmus PE, Heideman DA, Smit EF. Kuiper JL, et al. Br J Cancer. 2016 Dec 6;115(12):1504-1512. doi: 10.1038/bjc.2016.372. Epub 2016 Nov 22. Br J Cancer. 2016. PMID: 27875527 Free PMC article.

5

Surgical Treatment of Complications After High-Dose Chemoradiotherapy for Lung Cancer.

Dickhoff C, Dahele M, Hashemi SM, Senan S, Smit EF, Hartemink KJ, Paul MA. Dickhoff C, et al. Ann Thorac Surg. 2017 Aug;104(2):436-442. doi: 10.1016/j.athoracsur.2017.02.055. Epub 2017 May 26. Ann Thorac Surg. 2017. PMID: 28552373

6

High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes.

van de Ven R, Niemeijer AN, Stam AGM, Hashemi SMS, Slockers CG, Daniels JM, Thunnissen E, Smit EF, de Gruijl TD, de Langen AJ. van de Ven R, et al. Among authors: hashemi sms. ERJ Open Res. 2017 May 23;3(2):00110-2016. doi: 10.1183/23120541.00110-2016. eCollection 2017 Apr. ERJ Open Res. 2017. PMID: 28560238 Free PMC article.

7

Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion-Positive Advanced NSCLC.

van Veggel B, de Langen AJ, Hashemi SMS, Monkhorst K, Heideman DAM, Thunnissen E, Smit EF. van Veggel B, et al. Among authors: hashemi sms. J Thorac Oncol. 2018 Aug;13(8):1222-1226. doi: 10.1016/j.jtho.2018.04.012. Epub 2018 Apr 24. J Thorac Oncol. 2018. PMID: 29702285 Free article.

8

Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment.

de Langen AJ, Jebbink M, Hashemi SMS, Kuiper JL, de Bruin-Visser J, Monkhorst K, Thunnissen E, Smit EF. de Langen AJ, et al. Among authors: hashemi sms. Br J Cancer. 2018 Aug;119(5):558-564. doi: 10.1038/s41416-018-0194-7. Epub 2018 Jul 31. Br J Cancer. 2018. PMID: 30061586 Free PMC article. Clinical Trial.

9

Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses.

van Veggel B, de Langen AJ, Hashemi S, Monkhorst K, Rosenberg EH, Heideman DAM, Radonic T, Smit EF. van Veggel B, et al. Lung Cancer. 2018 Oct;124:130-134. doi: 10.1016/j.lungcan.2018.07.030. Epub 2018 Jul 30. Lung Cancer. 2018. PMID: 30268451 Free article.

10

ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib.

Thunnissen E, Lissenberg-Witte BI, van den Heuvel MM, Monkhorst K, Skov BG, Sørensen JB, Mellemgaard A, Dingemans AMC, Speel EJM, de Langen AJ, Hashemi SMS, Bahce I, van der Drift MA, Looijen-Salamon MG, Gosney J, Postmus PE, Samii SMS, Duplaquet F, Weynand B, Durando X, Penault-Llorca F, Finn S, Grady AO, Oz B, Akyurek N, Buettner R, Wolf J, Bubendorf L, Duin S, Marondel I, Heukamp LC, Timens W, Schuuring EMD, Pauwels P, Smit EF. Thunnissen E, et al. Among authors: hashemi sms. Lung Cancer. 2019 Dec;138:13-18. doi: 10.1016/j.lungcan.2019.09.023. Epub 2019 Oct 3. Lung Cancer. 2019. PMID: 31630043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters